GO:0015136 sialic acid transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015136 defines the molecular function that enables the transfer of sialic acid across a membrane.
• Sialic acid transporters are essential for supplying sialic acid to the Golgi for sialylation of glycoproteins and glycolipids.
• The CMP-sialic acid transporter (SLC35A1) is the most studied member, and its activity is critical for cell surface sialylation.
• Mutations in sialic acid transporter genes cause human disorders such as infantile sialic acid storage disease.
• Sialic acid transport influences neurotransmitter uptake and calcium channel modulation, linking it to neuronal and cardiovascular physiology.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect sialic acid transporter function.
Description
Sialic acid transmembrane transporter activity (GO:0015136) is a molecular function that mediates the movement of sialic acid across cellular membranes. This activity is fundamental for the proper glycosylation of proteins and lipids, as sialic acid must be transported into the Golgi apparatus to serve as a substrate for sialyltransferases. The most extensively characterized transporter is the CMP-sialic acid transporter (CMP-SiaT), encoded by SLC35A1, which exchanges CMP-sialic acid into the Golgi lumen. Defects in this transport process lead to impaired sialylation and have been linked to human diseases, including infantile sialic acid storage disease. Understanding the molecular mechanism, regulation, and physiological roles of sialic acid transporters is therefore of broad biomedical importance.
sialic acid transmembrane transporter activity At A Glance
| GO ID | GO:0015136 |
|---|---|
| GO term | sialic acid transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Transfer of sialic acid across membranes |
| Related transporters | CMP-sialic acid transporter (SLC35A1), SLC17A5 |
| Associated diseases | Infantile sialic acid storage disease, sialylation disorders |
| Research methods | CRISPR knockout, transport assays, glycoproteomics |
What Is GO:0015136?
According to the Gene Ontology, GO:0015136 (sialic acid transmembrane transporter activity) enables the transfer of sialic acid from one side of a membrane to the other. This activity is classified as a molecular function and is essential for the distribution of sialic acid within cells and across cellular compartments.
Why Is sialic acid transmembrane transporter activity Important in Cell Biology?
Sialic acid transmembrane transporter activity is crucial for maintaining cellular sialylation, which affects cell-cell communication, immune recognition, and signaling. Disruption of this activity leads to defective glycosylation and has been implicated in developmental and neurological disorders. Moreover, sialic acid transport modulates the activity of neurotransmitter transporters and calcium channels, highlighting its role in neuronal and cardiovascular physiology.
• Required for Golgi sialylation of glycoproteins and glycolipids.
• Mutations cause infantile sialic acid storage disease and other sialylation defects.
• Influences GABA uptake activity via sialic acid modulation of GAT1.
• Modulates myocardial and vascular activity of calcium channel ligands.
• Essential for immune cell function and pathogen recognition.
• Target for engineering sialylation in biotherapeutics.
• Key to understanding Golgi transporter specificity and substrate recognition.
• Provides insights into membrane transport mechanisms and evolution.
What Happens During sialic acid transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs the sialic acid molecule.
The CMP-sialic acid transporter recognizes its substrate through specific amino acid residues in hydrophilic loop regions, as shown by mutational analysis. Chimeric studies between UDP-galactose and CMP-sialic acid transporters identified residues critical for substrate specificity.
Translocation across the membrane
In simple terms: The transporter then flips the sialic acid to the other side of the membrane.
After binding, the transporter undergoes conformational changes to move CMP-sialic acid into the Golgi lumen, a process that is energy-dependent and coupled to antiport with CMP. Functional insights from CHO mutants reveal that the transporter is essential for Golgi sialylation.
Release and recycling
In simple terms: The sialic acid is released inside the Golgi, and the transporter resets.
Once inside the Golgi, CMP-sialic acid is used by sialyltransferases, and the transporter recycles back to the starting conformation. This cycle is vital for continuous sialylation.
Key Genes Involved in GO:0015136 sialic acid transmembrane transporter activity
The following genes encode proteins that exhibit or regulate sialic acid transmembrane transporter activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC35A1 | CMP-sialic acid transporter | Main Golgi transporter for sialylation; mutations cause sialylation disorders |
| SLC17A5 | Sialic acid transporter (sialin) | Lysosomal sialic acid exporter; mutations cause infantile sialic acid storage disease |
| SLC35A2 | UDP-galactose transporter | Related nucleotide sugar transporter; chimeras with SLC35A1 reveal specificity |
| SLC35A3 | UDP-N-acetylglucosamine transporter | Comparative studies of Golgi transporters |
| GAT1 (SLC6A1) | GABA transporter | Sialic acid modulates its uptake activity |
| CACNA1C | Calcium channel | Sialic acid removal affects channel ligand activity |
| CASD1 | Sialic acid O-acetylation | Interplay with SLC33A1-dependent Golgi sialic acid transport |
| SLC33A1 | Acetyl-CoA transporter | Affects Golgi sialic acid O-acetylation |
| ST3GAL1 | Sialyltransferase | Uses CMP-sialic acid in Golgi; downstream of transport |
| ST6GAL1 | Sialyltransferase | Uses CMP-sialic acid in Golgi |
| NEU1 | Sialidase | Lysosomal sialic acid release; related to sialic acid metabolism |
| GLB1 | Beta-galactosidase | Defects cause GM1 gangliosidosis with sialic acid accumulation |
| SLC35B1 | UDP-xylose transporter | Related Golgi transporter family |
| SLC35C1 | GDP-fucose transporter | Related Golgi transporter family |
| SLC35D1 | UDP-glucuronic acid transporter | Related Golgi transporter family |
| SLC35E1 | Putative transporter | Unknown function, potential sialic acid transport |
| SLC35F1 | Putative transporter | Unknown function, potential sialic acid transport |
How Is sialic acid transmembrane transporter activity Regulated?
Sialic acid transmembrane transporter activity is regulated at multiple levels. The expression of SLC35A1 is controlled by transcription factors responsive to cellular sialylation status. Additionally, the activity of the CMP-sialic acid transporter can be modulated by substrate availability and feedback inhibition by CMP. Post-translational modifications and interactions with other Golgi proteins may also influence transport efficiency. In the lysosome, SLC17A5 (sialin) activity is regulated by pH and membrane potential.
sialic acid transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC17A5 | Infantile sialic acid storage disease | Knockout mice, patient-derived fibroblasts |
| SLC35A1 | Sialylation disorder | CRISPR knockout in HEK293 or CHO cells |
| GAT1 (SLC6A1) | Epilepsy, GABA uptake defect | Point mutation knock-in mice |
| CACNA1C | Cardiovascular disease | Overexpression in cardiomyocytes |
| CASD1 | Sialic acid O-acetylation defect | Knockout cell lines |
Infantile sialic acid storage disease
Mutations in SLC17A5, which encodes the lysosomal sialic acid transporter sialin, cause infantile sialic acid storage disease (ISSD), characterized by accumulation of free sialic acid in lysosomes and severe neurological impairment. A novel SLC17A5 variant was recently identified in a patient with hyporegenerative anemia and distinct neuroimaging features.
Sialylation disorders
Defects in the Golgi CMP-sialic acid transporter (SLC35A1) lead to impaired sialylation of glycoproteins and glycolipids, resulting in developmental delay, immune deficiency, and coagulation abnormalities.
Neurological and cardiovascular implications
Sialic acid removal modulates GABA uptake by GAT1, suggesting a role in neuronal excitability. In the cardiovascular system, sialic acid removal affects the activity of calcium channel ligands, linking sialic acid transport to myocardial and vascular function.
From sialic acid transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC35A1 affect Golgi sialylation? | CRISPR knockout in HEK293 cells |
| What residues are required for CMP-sialic acid binding? | Point mutations in SLC35A1 |
| Can we tag SLC17A5 to track lysosomal localization? | Knock-in of fluorescent tag |
| Does overexpression of SLC35A1 increase sialylation? | Overexpression in CHO cells |
| How does sialic acid transport affect GABA uptake? | Point mutation in GAT1 |
| What is the role of SLC33A1 in Golgi O-acetylation? | Knockout and rescue |
How to Study the sialic acid transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive transport assay | Sialic acid uptake into Golgi vesicles | Functional characterization of SLC35A1 |
| Lectin blotting | Cell surface sialylation | Knockout validation |
| Mass spectrometry | Sialic acid composition | Glycoproteomics |
| CRISPR screen | Genes affecting sialylation | Identify novel transporters |
| Live-cell imaging | Subcellular localization | Golgi trafficking |
| Site-directed mutagenesis | Residues critical for transport | Substrate specificity |
| qPCR | Expression levels | Regulation studies |
| Western blot | Protein expression | Knockout validation |
Transport assays
Radioactive or fluorescent sialic acid analogs can be used to measure transport activity in isolated Golgi vesicles or intact cells. Such assays are essential to confirm the function of candidate transporters.
Glycoproteomics and lectin blotting
Changes in sialylation can be assessed by lectin blotting (e.g., SNA, MAL-II) or mass spectrometry-based glycoproteomics to quantify sialic acid content on glycoproteins.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes required for sialic acid transport and sialylation, using lectin-based selection or cytotoxicity assays.
Imaging and subcellular localization
Fluorescently tagged transporters (e.g., GFP-SLC35A1) allow live-cell imaging to study Golgi localization and trafficking dynamics.
How CRISPR Can Be Used to Study GO:0015136 sialic acid transmembrane transporter activity
Knockout
CRISPR knockout of SLC35A1 or SLC17A5 in cell lines such as HEK293 or HeLa can abolish sialic acid transport, leading to hyposialylation and providing a clean background to study transporter function.
Point Mutation
Introducing point mutations in residues identified as critical for substrate binding (e.g., in hydrophilic loops of SLC35A1) allows precise dissection of the transport mechanism and substrate specificity.
Knock-in
Knock-in of epitope tags (e.g., HA, GFP) into the endogenous SLC35A1 or SLC17A5 loci enables visualization and immunoprecipitation of the transporter at physiological expression levels.
Overexpression
Overexpression of SLC35A1 or SLC17A5 in CHO or HEK293 cells can enhance sialylation capacity, useful for bioproduction of sialylated therapeutics.
How EDITGENE Supports sialic acid transmembrane transporter activity Research
Researchers studying sialic acid transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in sialylation, transport, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for sialic acid transmembrane transporter activity research.
Frequently Asked Questions About sialic acid transmembrane transporter activity
What is sialic acid transmembrane transporter activity?
It is a molecular function (GO:0015136) that enables the transfer of sialic acid across a membrane, essential for sialylation.
What genes are involved in sialic acid transmembrane transporter activity?
Key genes include SLC35A1 (CMP-sialic acid transporter) and SLC17A5 (sialin), among others.
What diseases are associated with defects in sialic acid transport?
Mutations in SLC17A5 cause infantile sialic acid storage disease, and SLC35A1 defects lead to sialylation disorders.
How is sialic acid transported into the Golgi?
The CMP-sialic acid transporter (SLC35A1) mediates antiport of CMP-sialic acid into the Golgi lumen.
What is the role of SLC35A1?
SLC35A1 encodes the Golgi CMP-sialic acid transporter, critical for sialylation of proteins and lipids.
Can CRISPR be used to study sialic acid transporters?
Yes, CRISPR knockout, knock-in, and point mutations are powerful for dissecting transporter function.
What methods measure sialic acid transport activity?
Radioactive transport assays, lectin blotting, and glycoproteomics are commonly used.
How does sialic acid affect neuronal function?
Sialic acid modulates GABA uptake by GAT1, influencing neuronal excitability.
What is infantile sialic acid storage disease?
A rare lysosomal storage disorder caused by mutations in SLC17A5, leading to sialic acid accumulation.
Are there animal models for sialic acid transport defects?
Yes, knockout mice for SLC17A5 and other transporters exist, and patient-derived cells are used.
Conclusion
Sialic acid transmembrane transporter activity (GO:0015136) is a fundamental molecular function required for proper sialylation and cellular homeostasis. Its dysregulation leads to severe human diseases, underscoring the importance of understanding its mechanism and regulation. CRISPR-based models and advanced glycoproteomics will continue to illuminate the roles of sialic acid transporters in health and disease.
References
- 1. Hu J et al.. 2011. Involvement of sialic acid in the regulation of γ--aminobutyric acid uptake activity of γ-aminobutyric acid transporter 1.. Glycobiology 21(3):329-39 PMID: 21045010
- 2. Albers M et al.. 2026. Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysis.. Nat Commun 17(1) PMID: 41917001
- 3. Lim SF et al.. 2008. The Golgi CMP-sialic acid transporter: A new CHO mutant provides functional insights.. Glycobiology 18(11):851-60 PMID: 18713811
- 4. Werner G et al.. 1991. Sialic acid removal modulates the myocardial and vascular activity of calcium channel ligands.. Biochem Pharmacol 42 Suppl:S77-87 PMID: 1722670
- 5. Aoki K et al.. 1999. Expression and activity of chimeric molecules between human UDP-galactose transporter and CMP-sialic acid transporter.. J Biochem 126(5):940-50 PMID: 10544289
- 6. Chan KF et al.. 2010. Identification of essential amino acid residues in the hydrophilic loop regions of the CMP-sialic acid transporter and UDP-galactose transporter.. Glycobiology 20(6):689-701 PMID: 20181793
- 7. Takeshima-Futagami T et al.. 2012. Amino acid residues important for CMP-sialic acid recognition by the CMP-sialic acid transporter: analysis of the substrate specificity of UDP-galactose/CMP-sialic acid transporter chimeras.. Glycobiology 22(12):1731-40 PMID: 22833315
- 8. Cappozzo F et al.. 2025. A novel SLC17A5 variant in infantile sialic acid storage disease with hyporegenerative anemia: Neuroimaging insights and literature review.. Mol Genet Metab Rep 45:101284 PMID: 41459346
